152 related articles for article (PubMed ID: 27486530)
1. Intravenous Methylprednisolone-Induced Nocturnal Sinus Bradycardia in a Multiple Sclerosis Patient.
Osuagwu F; Jahnke B
Prim Care Companion CNS Disord; 2016; 18(2):. PubMed ID: 27486530
[No Abstract] [Full Text] [Related]
2. Low dose methylprednisolone induced bradycardia.
Darling HS; Marwah V; Rajput AK; Varma PP; Singh KK
J Assoc Physicians India; 2013 Dec; 61(12):920-2. PubMed ID: 24968553
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.
Jongen PJ; Stavrakaki I; Voet B; Hoogervorst E; van Munster E; Linssen WH; Sinnige LG; Verhagen WI; Visser LH; van der Kruijk R; Verheul F; Boringa J; Heerings M; Gladdines W; Lönnqvist F; Gaillard P
J Neurol; 2016 Aug; 263(8):1641-51. PubMed ID: 27272956
[TBL] [Abstract][Full Text] [Related]
4. Severe bradycardia after a methylprednisolone "minipulse" treatment.
Pudil R; Hrncir Z
Arch Intern Med; 2001 Jul; 161(14):1778-9. PubMed ID: 11485514
[No Abstract] [Full Text] [Related]
5. Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury.
Grilli E; Galati V; Petrosillo N; Del Nonno F; Baiocchini A
Liver Int; 2015 Feb; 35(2):674-6. PubMed ID: 24906135
[No Abstract] [Full Text] [Related]
6. Effect of high-dose intravenous methyl-prednisolone treatment on intraocular pressure in multiple sclerosis patients with relapse.
Acar M; Gedizlioglu M; Koskderelioglu A; Ozturk F; Kilinc S; Talay N
Eur Neurol; 2012; 68(1):20-2. PubMed ID: 22677889
[TBL] [Abstract][Full Text] [Related]
7. Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
Ferraro D; Mirante VG; Losi L; Villa E; Simone AM; Vitetta F; Federzoni L; Nichelli PF; Sola P
Neurologist; 2015 Jun; 19(6):153-4. PubMed ID: 26075468
[TBL] [Abstract][Full Text] [Related]
8. Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
Kundu A; Fitzgibbons TP
J Med Case Rep; 2015 Sep; 9():216. PubMed ID: 26400725
[TBL] [Abstract][Full Text] [Related]
9. Intractable hiccups induced by high-dose intravenous methylprednisolone in a patient with multiple sclerosis.
Iijima M; Uchigata M; Ohashi T; Kato H
Eur J Neurol; 2006 Feb; 13(2):201-2. PubMed ID: 16490055
[No Abstract] [Full Text] [Related]
10. Rebound of disease activity during pregnancy after withdrawal of fingolimod.
Sempere AP; Berenguer-Ruiz L; Feliu-Rey E
Eur J Neurol; 2013 Aug; 20(8):e109-10. PubMed ID: 23829238
[No Abstract] [Full Text] [Related]
11. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
Then Bergh F; Kümpfel T; Schumann E; Held U; Schwan M; Blazevic M; Wismüller A; Holsboer F; Yassouridis A; Uhr M; Weber F; Daumer M; Trenkwalder C; Auer DP
BMC Neurol; 2006 May; 6():19. PubMed ID: 16719908
[TBL] [Abstract][Full Text] [Related]
12. Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Shaygannejad V; Ashtari F; Alinaghian M; Norouzi R; Salari M; Fatehi F
Clin Neuropharmacol; 2013; 36(1):1-3. PubMed ID: 23334067
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
14. [Corticotherapy and suicidal behavior: A case report].
Carle G; Abgrall-Barbry G
Encephale; 2016 Jun; 42(3):272-6. PubMed ID: 26923998
[TBL] [Abstract][Full Text] [Related]
15. Sinus bradycardia after intravenous pulse methylprednisolone.
Akikusa JD; Feldman BM; Gross GJ; Silverman ED; Schneider R
Pediatrics; 2007 Mar; 119(3):e778-82. PubMed ID: 17308245
[TBL] [Abstract][Full Text] [Related]
16. Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
Créange A; Debouverie M; Jaillon-Rivière V; Taithe F; Liban D; Moutereau A; Clavelou P; Defer G
Mult Scler; 2009 Sep; 15(9):1085-91. PubMed ID: 19556312
[TBL] [Abstract][Full Text] [Related]
17. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Le Page E; Veillard D; Laplaud DA; Hamonic S; Wardi R; Lebrun C; Zagnoli F; Wiertlewski S; Deburghgraeve V; Coustans M; Edan G; ;
Lancet; 2015 Sep; 386(9997):974-81. PubMed ID: 26135706
[TBL] [Abstract][Full Text] [Related]
18. Severe bradycardia: An unreported adverse infusion-associated reaction (IAR) with alemtuzumab.
Nerrant E; Thouvenot E; Castelnovo G
Rev Neurol (Paris); 2017 Mar; 173(3):175-176. PubMed ID: 28320519
[No Abstract] [Full Text] [Related]
19. Multiple sclerosis.
Boggild M; Ford H
Clin Evid; 2002 Jun; (7):1195-207. PubMed ID: 12230737
[No Abstract] [Full Text] [Related]
20. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
Cohen JA; Imrey PB; Calabresi PA; Edwards KR; Eickenhorst T; Felton WL; Fisher E; Fox RJ; Goodman AD; Hara-Cleaver C; Hutton GJ; Mandell BF; Scott TF; Zhang H; Apperson-Hansen C; Beck GJ; Houghtaling PL; Karafa MT; Stadtler M;
Neurology; 2009 Feb; 72(6):535-41. PubMed ID: 19204263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
